Users Discontinuing Weight-Loss Medications Put On Weight Far More Rapidly Compared to Those on Conventional Diets

A recent study indicates that individuals who come off popular slimming jabs like Mounjaro or Wegovy may regain shed pounds far faster than those who stop traditional lifestyle regimens.

Research printed in a prominent health publication demonstrates that while obese individuals often shed a large proportion of their body weight while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.

"People buying these drugs need to be cognizant of the risk of quick rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.

Such speed of regain implies a return to pre-treatment weight in about one and a half years.

Analyzing Approaches

The research, which reviewed dozens of trials involving over 9,000 of patients, compared the results of GLP-1 agonists with conventional dieting.

Scientists note that individuals who shed pounds through dieting typically have a less rapid weight regain—around 0.1 kg a month—post-intervention.

Understanding the Rapid Regain

Nutrition scientists suggest the way of the drugs is key to understanding the accelerated regain.

These medications mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.

"Long-term administration of the hormone concentrations far above than the body's typical production could lead to the system to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher.

"Withdrawal of this medication means hunger is uncontrolled, making overeating a significant risk."

A Chronic Disease?

Health authorities advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended lifestyle changes.

Professionals say that, considering the high risk of relapse, the therapy is often long-term.

This opinion is supported by pharmaceutical companies, who note that the results "emphasize the chronic nature of obesity," similar to managing diseases like high blood pressure.

Patient Experiences

Users who have come off the medication explain a sudden resurgence of hunger.

"It felt as if a switch activating and you're instantly starving," described an individual.

The struggle is worsened if patients have not adopted permanent lifestyle or habit modifications during therapy.

Widespread Interest

Recent estimates suggest that a significant number of adults in the UK have used these injections in the last 12 months, with demand remaining high.

• Use is higher among women than males.
• The 40s and 50s demographic shows the highest usage rates.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, experts caution that while these medications are powerful tools for weight loss, they are not a magic cure and long-term success likely depends on integrated behavioural changes.